CD274 and non-small cell lung carcinoma: Specifically, Zhang et al. demonstrated that inhibition of an endogenous autophagy inhibitor, mTORC1/2, resulted in a decrease in PD-L1 levels in human non-small cell lung cancer (NSCLC) cells [65].